Pricing Log in Create free account

Inogen, Inc (INGN) vs Standard BioTools Inc. (LAB)

Inogen, Inc and Standard BioTools Inc. are both Medical Devices companies. Standard BioTools Inc. is the larger, with a market value of $245.7M against $179.7M — 1.4× the size. Inogen, Inc has negative trailing earnings, so its P/E is not meaningful; Standard BioTools Inc. trades at 1.8×. Standard BioTools Inc. grew revenue faster over the last twelve months: 35.3% against 3.15%. Standard BioTools Inc. has the higher net margin (157.6% vs −6.94%) and the lower return on invested capital (−54.2% vs −28.4%). Across the 18 metrics below, Standard BioTools Inc. leads on 11 and Inogen, Inc on 7.

Valuation

Metric INGN LAB Medical Devices median
P/E n/m 1.80 25.58
P/S 0.52 2.89 2.54
P/B 1.04 0.44 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m 2.63 11.51
EV/Sales 0.21 (2.51) 2.72
Earnings yield (13.33%) 55.53% (12.82%)
Free cash flow yield (4.30%) (29.61%) (8.18%)

Profitability

Metric INGN LAB Medical Devices median
Gross margin 44.51% 52.18% 57.76%
Operating margin (8.71%) (97.47%) (15.07%)
Net margin (6.94%) 157.62% (14.45%)
Free cash flow margin (2.22%) (77.76%) (3.88%)
Return on equity (13.14%) 27.86% (10.35%)
Return on assets (8.23%) 22.65% (17.26%)
Return on invested capital (28.35%) (54.18%) (5.27%)

Growth

Metric INGN LAB Medical Devices median
Revenue growth (TTM) 3.15% 35.25% 10.41%
EPS growth (last fiscal year) 43.42% 61.54% 28.17%
Revenue growth, 5-year CAGR 2.48% (9.19%) 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INGN LAB Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 2.74 9.75 2.74
Net debt to EBITDA 12.66 1.84 0.54

Dividend

Metric INGN LAB Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric INGN LAB Medical Devices median
Market cap 179.67m 245.72m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack